We are currently recruiting patients for a resident research project. The project involves assessing potential effects of Trazodone on echocardiogram variables and arrhythmias in older Boxers (6-9 years old) with presumptive mild ARVC (arrhythmogenic right ventricular cardiomyopathy, aka “Boxer cardiomyopathy”). Recent research studies have been performed evaluating Trazodone’s effects in normal / healthy dogs. The importance of this study is to ensure this medication is safe for cardiac patients with preexisting cardiac disease. This is especially important as Trazodone is a VERY common anti-anxiety drug used in veterinary medicine to reduce stress, especially for patients with in-hospital anxiety.
Below is a summary of the specific inclusion criteria and *FREE* diagnostics. Prior to enrolling in the study, screening tests will need to be performed to determine if the patient meets the criteria for occult / mild ARVC. If interested in the study and you would like more information, please contact Dr. Clinton Lynn (Cardiology Resident) at Clynn@mspca.org
Study Information:
1. Population
- Boxers between the ages of 6-9 years old
- Diagnosis of presumptive ARVC that ARE NOT receiving medications
- Any otherwise healthy Boxer may be considered; however, we will need to do initial screening with a 24-hour Holter to ensure they meet the study qualifications
- Unfortunately, dogs with significant medical issues or other cardiac diseases cannot be included in the study
2. Baseline diagnostics (Included in the study – aka FREE OF CHARGE to client)
-
- Full echocardiogram
- 24-hour Holter monitor evaluation
- Full labwork including:
- Complete blood count
- Chemistry profile
- T4
- 4DX Snap
- ARVC genetic testing